A complement inhibitor used for specified myasthenia gravis.
Profile scope: Zilucoplan injection. Confirm the exact product and route; formulations and combination products are not interchangeable.
Possible side effects
Injection-site discomfort, loose stools, or skin changes may occur.
Serious risks and warning signs
Meningococcal infection can progress rapidly and be fatal, even after vaccination. Fever with severe headache, neck stiffness, confusion, or rash needs emergency assessment. Follow vaccination, prevention, and safety-card instructions.
A question for your healthcare team
What vaccination and infection-prevention plan applies, and can I explain my emergency response to possible meningococcal symptoms?
What to do with this information
Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.
Sources
Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.